|
J Biol Chem, Vol. 274, Issue 27, 19434-19440, July 2, 1999
Identification of Three Major Phosphorylation Sites within
HIV-1 Capsid
ROLE OF PHOSPHORYLATION DURING THE EARLY STEPS OF INFECTION
Christine
Cartier ,
Peggy
Sivard ,
Corinne
Tranchat ,
Didier
Decimo¶,
Claude
Desgranges , and
Véronique
Boyer
From Virus des Hépatites, Rétrovirus
Humains et Pathologies Associées, INSERM U271, 151 Cours. A. Thomas, 69 424 Lyon Cedex 03, France and the ¶ LaboRetro,
Unité de Virologie Humaine, INSERM U412, Ecole Normale
Supérieure de Lyon, 46 allée d'Italie, 69 364 Lyon Cedex
07, France
We previously reported the presence of two
cellular serine/threonine protein kinases incorporated in human
immunodeficiency virus type 1 (HIV-1) particles. One protein kinase is
MAPK ERK2 (mitogen-activated protein kinase), whereas the other one, a
53-kDa protein, still needs to be identified. Furthermore, we
demonstrated that the capsid protein CAp24 is phosphorylated by one of
those two virion-associated protein kinases (Cartier, C., Deckert, M., Grangeasse, C., Trauger, R., Jensen, F., Bernard, A., Cozzone, A.,
Desgranges, C., and Boyer, V. (1997) J. Virol. 71, 4832-4837). In this study, we showed that CAp24 is not a direct
substrate of MAPK ERK2. Moreover, using site-directed mutagenesis of
each of the 9 serine residues of CAp24, we demonstrated the
phosphorylation of 3 serine residues (Ser-109, Ser-149, and Ser-178) in
the CAp24. Substitution of each serine residue did not affect viral
budding, nor viral structure. By contrast, substitution of Ser-109,
Ser-149, or Ser-178 affects viral infectivity by preventing the reverse transcription process to be completely achieved. Our results suggest that CAp24 serine phosphorylation is essential for viral uncoating process.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Schneidewind, Z. L. Brumme, C. J. Brumme, K. A. Power, L. L. Reyor, K. O'Sullivan, A. Gladden, U. Hempel, T. Kuntzen, Y. E. Wang, et al.
Transmission and Long-Term Stability of Compensated CD8 Escape Mutations
J. Virol.,
April 15, 2009;
83(8):
3993 - 3997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schneidewind, M. A. Brockman, R. Yang, R. I. Adam, B. Li, S. Le Gall, C. R. Rinaldo, S. L. Craggs, R. L. Allgaier, K. A. Power, et al.
Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication
J. Virol.,
November 15, 2007;
81(22):
12382 - 12393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Law, C. S. Ilkow, W.-P. Tzeng, M. Rawluk, D. T. Stuart, T. K. Frey, and T. C. Hobman
Analyses of Phosphorylation Events in the Rubella Virus Capsid Protein: Role in Early Replication Events
J. Virol.,
July 15, 2006;
80(14):
6917 - 6925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jin, C. Chen, and R. C. Montelaro
Equine Infectious Anemia Virus Gag p9 Function in Early Steps of Virus Infection and Provirus Production
J. Virol.,
July 15, 2005;
79(14):
8793 - 8801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Rue, J. W. Roos, P. M. Tarwater, J. E. Clements, and S. A. Barber
Phosphorylation and Proteolytic Cleavage of Gag Proteins in Budded Simian Immunodeficiency Virus
J. Virol.,
February 15, 2005;
79(4):
2484 - 2492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Bennett, A. M. L. Lever, and J. F. Allen
Human Immunodeficiency Virus Type 2 Gag Interacts Specifically with PRP4, a Serine-Threonine Kinase, and Inhibits Phosphorylation of Splicing Factor SF2
J. Virol.,
October 15, 2004;
78(20):
11303 - 11312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Moreau, G. Belliard, C. D. Partidos, F. Pradezinsky, H. Le Buanec, S. Muller, and C. Desgranges
Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides
J. Gen. Virol.,
October 1, 2004;
85(10):
2893 - 2901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Hemonnot, C. Cartier, B. Gay, S. Rebuffat, M. Bardy, C. Devaux, V. Boyer, and L. Briant
The Host Cell MAP Kinase ERK-2 Regulates Viral Assembly and Release by Phosphorylating the p6gag Protein of HIV-1
J. Biol. Chem.,
July 30, 2004;
279(31):
32426 - 32434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yamashita and M. Emerman
Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells
J. Virol.,
June 1, 2004;
78(11):
5670 - 5678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Narayan and J. A. T. Young
Reconstitution of retroviral fusion and uncoating in a cell-free system
PNAS,
May 18, 2004;
101(20):
7721 - 7726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Owens, B. Song, M. J. Perron, P. C. Yang, M. Stremlau, and J. Sodroski
Binding and Susceptibility to Postentry Restriction Factors in Monkey Cells Are Specified by Distinct Regions of the Human Immunodeficiency Virus Type 1 Capsid
J. Virol.,
May 15, 2004;
78(10):
5423 - 5437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cartier, B. Hemonnot, B. Gay, M. Bardy, C. Sanchiz, C. Devaux, and L. Briant
Active cAMP-dependent Protein Kinase Incorporated within Highly Purified HIV-1 Particles Is Required for Viral Infectivity and Interacts with Viral Capsid Protein
J. Biol. Chem.,
September 12, 2003;
278(37):
35211 - 35219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. I. Ivanov, P. Puustinen, R. Gabrenaite, H. Vihinen, L. Ronnstrand, L. Valmu, N. Kalkkinen, and K. Makinen
Phosphorylation of the Potyvirus Capsid Protein by Protein Kinase CK2 and Its Relevance for Virus Infection
PLANT CELL,
September 1, 2003;
15(9):
2124 - 2139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. del Alamo, J. L. Neira, and M. G. Mateu
Thermodynamic Dissection of a Low Affinity Protein-Protein Interface Involved in Human Immunodeficiency Virus Assembly
J. Biol. Chem.,
July 18, 2003;
278(30):
27923 - 27929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kock, M. Kann, G. Putz, H. E. Blum, and F. von Weizsacker
Central Role of a Serine Phosphorylation Site within Duck Hepatitis B Virus Core Protein for Capsid Trafficking and Genome Release
J. Biol. Chem.,
July 18, 2003;
278(30):
28123 - 28129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Gaddis, E. Chertova, A. M. Sheehy, L. E. Henderson, and M. H. Malim
Comprehensive Investigation of the Molecular Defect in vif-Deficient Human Immunodeficiency Virus Type 1 Virions
J. Virol.,
May 15, 2003;
77(10):
5810 - 5820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. K. von Schwedler, K. M. Stray, J. E. Garrus, and W. I. Sundquist
Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein
J. Virol.,
May 1, 2003;
77(9):
5439 - 5450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yueh and S. P. Goff
Phosphorylated Serine Residues and an Arginine-Rich Domain of the Moloney Murine Leukemia Virus p12 Protein Are Required for Early Events of Viral Infection
J. Virol.,
February 1, 2003;
77(3):
1820 - 1829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Forshey, U. von Schwedler, W. I. Sundquist, and C. Aiken
Formation of a Human Immunodeficiency Virus Type 1 Core of Optimal Stability Is Crucial for Viral Replication
J. Virol.,
May 3, 2002;
76(11):
5667 - 5677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Muller, T. Patschinsky, and H.-G. Krausslich
The Late-Domain-Containing Protein p6 Is the Predominant Phosphoprotein of Human Immunodeficiency Virus Type 1 Particles
J. Virol.,
February 1, 2002;
76(3):
1015 - 1024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-J. Mu, D.-S. Chen, and P.-J. Chen
The Conserved Serine 177 in the Delta Antigen of Hepatitis Delta Virus Is One Putative Phosphorylation Site and Is Required for Efficient Viral RNA Replication
J. Virol.,
October 1, 2001;
75(19):
9087 - 9095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Müller, U. Tessmer, U. Schubert, and H.-G. Kräusslich
Human Immunodeficiency Virus Type 1 Vpr Protein Is Incorporated into the Virion in Significantly Smaller Amounts than Gag and Is Phosphorylated in Infected Cells
J. Virol.,
October 15, 2000;
74(20):
9727 - 9731.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Legastelois and C. Desgranges
Design and Intracellular Activity of a Human Single-Chain Antibody to Human Immunodeficiency Virus Type 1 Conserved gp41 Epitope
J. Virol.,
June 15, 2000;
74(12):
5712 - 5715.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|